Wellcome Trust’s PE portfolio turns cashflow negative amid capital call slowdown

The UK’s £34.6bn medical research endowment warns of difficult period ahead for private equity, marked by subdued distributions and longer fundraising cycles.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.